CoChat

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles

Open access

Abstract

BACKGROUND: The eye is an excellent candidate for gene therapy as it is immune privileged and much of the disease-causing genetics are well understood. Towards this goal, we evaluated the efficiency of compacted DNA nanoparticles as a system for non-viral gene transfer to ocular tissues. The compacted DNA nanoparticles examined here have been shown to be safe and effective in a human clinical trial, have no theoretical limitation on plasmid size, do not provoke immune responses, and can be highly concentrated. METHODS AND FINDINGS: Here we show that these nanoparticles can be targeted to different tissues within the eye by varying the site of injection. Almost all cell types of the eye were capable of transfection by the nanoparticle and produced robust levels of gene expression that were dose-dependent. Most impressively, subretinal delivery of these nanoparticles transfected nearly all of the photoreceptor population and produced expression levels almost equal to that of rod opsin, the highest expressed gene in the retina. CONCLUSIONS: As no deleterious effects on retinal function were observed, this treatment strategy appears to be clinically viable and provides a highly efficient non-viral technology to safely deliver and express nucleic acids in the retina and other ocular tissues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0000038

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Differential shape of the trifluoroacetate (TFA) and acetate (AC) nanoparticles as visualized by electron microscopy. During compaction of the EGFP expression plasmid, the presence of TFA as the lysine counterion produces ellipsoidal nanoparticles with a minor diameter <18 nm whereas acetate produces rods with a minor diameter <8 nm. Scale bar, 100 nM.
Figure 1 Differential shape of the trifluoroacetate (TFA) and acetate (AC) nanoparticles as visualized by electron microscopy. During compaction of the EGFP expression plasmid, the presence of TFA as the lysine counterion produces ellipsoidal nanoparticles with a minor diameter <18 nm whereas acetate produces rods with a minor diameter <8 nm. Scale bar, 100 nM.CC BY · PubMed Central
Figure 2 Ocular expression levels of EGFP mRNA after intravitreal injection. At 2 days post-intravitreal injection of 0.6 µg of compacted DNA, the lens, pigment epithelium/choroid/sclera (PECS), and retina were isolated. qRT-PCR was used to assess EGFP mRNA levels and normalized to the neuronal housekeeping gene HPRT. Both the AC-GFP and TFA-GFP nanoparticles produced substantial expression of EGFP in the lens as compared to the naked plasmid control. In the PECS (A) and retina (B), both nanoparticles produced EGFP mRNA at levels several fold higher than naked plasmid. No expression of EGFP was detected in any of the mock-injected samples.
Figure 2 Ocular expression levels of EGFP mRNA after intravitreal injection. At 2 days post-intravitreal injection of 0.6 µg of compacted DNA, the lens, pigment epithelium/choroid/sclera (PECS), and retina were isolated. qRT-PCR was used to assess EGFP mRNA levels and normalized to the neuronal housekeeping gene HPRT. Both the AC-GFP and TFA-GFP nanoparticles produced substantial expression of EGFP in the lens as compared to the naked plasmid control. In the PECS (A) and retina (B), both nanoparticles produced EGFP mRNA at levels several fold higher than naked plasmid. No expression of EGFP was detected in any of the mock-injected samples.CC BY · PubMed Central
Figure 3 EGFP localization in ocular tissues following intravitreal injection. Direct fluorescence microscopy was utilized to localize EGFP expression in ocular tissues at 2-days post-injection of 0.6 µg of compacted DNA. (A) Retinal autofluorescence was present in the outer segment of all samples including mock- and naked plasmid-injected eyes, however EGFP fluorescence was detected in the GCL of both the AC-GFP and TFA-GFP injected eyes. (B) Upon examination at higher magnification, EGFP expression was confined to the GCL in the AC-GFP-injected eyes, and present in the GCL and IPL of TFA-GFP-injected eyes. (C) Expression of EGFP was also detected in the cornea, trabecular meshwork, and lens following intravitreal injection of both TFA and AC nanoparticles (only AC shown). “FITC” channel imaging was performed as described in the Methods Section. OS: Outer Segment; ONL: Outer Nuclear Layer; INL: Inner Nuclear Layer; IPL: Inner Plexiform Layer; GCL: Ganglion Cell Layer; CO: Cornea; TM: Trabecular Meshwork; LE: Lens. Scale bars, 10 µM.
Figure 3 EGFP localization in ocular tissues following intravitreal injection. Direct fluorescence microscopy was utilized to localize EGFP expression in ocular tissues at 2-days post-injection of 0.6 µg of compacted DNA. (A) Retinal autofluorescence was present in the outer segment of all samples including mock- and naked plasmid-injected eyes, however EGFP fluorescence was detected in the GCL of both the AC-GFP and TFA-GFP injected eyes. (B) Upon examination at higher magnification, EGFP expression was confined to the GCL in the AC-GFP-injected eyes, and present in the GCL and IPL of TFA-GFP-injected eyes. (C) Expression of EGFP was also detected in the cornea, trabecular meshwork, and lens following intravitreal injection of both TFA and AC nanoparticles (only AC shown). “FITC” channel imaging was performed as described in the Methods Section. OS: Outer Segment; ONL: Outer Nuclear Layer; INL: Inner Nuclear Layer; IPL: Inner Plexiform Layer; GCL: Ganglion Cell Layer; CO: Cornea; TM: Trabecular Meshwork; LE: Lens. Scale bars, 10 µM.CC BY · PubMed Central
Figure 4 Ocular expression levels of EGFP mRNA after subretinal injection. At 2-days post-subretinal injection of 0.6 µg of compacted DNA, the lens, PECS, and retina were isolated, and qRT-PCR was used to assess EGFP mRNA levels. Both the AC-GFP and TFA-GFP nanoparticles produced substantial expression in the PECS and retina. In both tissues, the AC-GFP nanoparticle generated EGFP mRNA levels nearly 2-fold higher than the TFA-GFP nanoparticle. EGFP expression was also observed in the lens; however there was significant deviation between samples, possibly reflecting the amount of nanoparticle reflux into the vitreous because of back-pressure during syringe withdrawal following some of the subretinal injection procedures.
Figure 4 Ocular expression levels of EGFP mRNA after subretinal injection. At 2-days post-subretinal injection of 0.6 µg of compacted DNA, the lens, PECS, and retina were isolated, and qRT-PCR was used to assess EGFP mRNA levels. Both the AC-GFP and TFA-GFP nanoparticles produced substantial expression in the PECS and retina. In both tissues, the AC-GFP nanoparticle generated EGFP mRNA levels nearly 2-fold higher than the TFA-GFP nanoparticle. EGFP expression was also observed in the lens; however there was significant deviation between samples, possibly reflecting the amount of nanoparticle reflux into the vitreous because of back-pressure during syringe withdrawal following some of the subretinal injection procedures.CC BY · PubMed Central
Figure 5 EGFP localization in ocular tissues following subretinal injection. Direct fluorescence microscopy was utilized to localize EGFP expression in ocular tissues at 2-days post-injection of 0.6 µg of compacted DNA. (A) EGFP fluorescence was detected in the ONL and RPE of eyes injected with the AC-GFP and TFA-GFP nanoparticles, respectively. (B) EGFP was also detected within the optic nerve (asterisks) and the extraocular muscles following injection of the AC-GFP nanoparticle. Scale bars, 10 µM.
Figure 5 EGFP localization in ocular tissues following subretinal injection. Direct fluorescence microscopy was utilized to localize EGFP expression in ocular tissues at 2-days post-injection of 0.6 µg of compacted DNA. (A) EGFP fluorescence was detected in the ONL and RPE of eyes injected with the AC-GFP and TFA-GFP nanoparticles, respectively. (B) EGFP was also detected within the optic nerve (asterisks) and the extraocular muscles following injection of the AC-GFP nanoparticle. Scale bars, 10 µM.CC BY · PubMed Central
Figure 6 EGFP immunoreactivity following subretinal injection. To eliminate any artifacts due to retinal autofluorescence, immunohistochemistry was performed with a Cy-3-anti-GFP antibody on paraffin-embedded ocular sections from eyes taken at 2-days post-injection of 0.6 µg of compacted DNA. An absence of or minimal EGFP immunoreactivity was found in the mock-injected and naked plasmid-injected eyes, respectively. Examination of sections from eyes injected with the AC-GFP nanoparticle revealed high-level EGFP immunoreactivity in nearly all of the cells in the ONL. Lower levels of EGFP were also detected within the upper half of the INL. Scale bar, 10 µM.
Figure 6 EGFP immunoreactivity following subretinal injection. To eliminate any artifacts due to retinal autofluorescence, immunohistochemistry was performed with a Cy-3-anti-GFP antibody on paraffin-embedded ocular sections from eyes taken at 2-days post-injection of 0.6 µg of compacted DNA. An absence of or minimal EGFP immunoreactivity was found in the mock-injected and naked plasmid-injected eyes, respectively. Examination of sections from eyes injected with the AC-GFP nanoparticle revealed high-level EGFP immunoreactivity in nearly all of the cells in the ONL. Lower levels of EGFP were also detected within the upper half of the INL. Scale bar, 10 µM.CC BY · PubMed Central
Figure 7 Assessment of retinal function following subretinal injection. ERG analyses were performed in adult Balb/c mice (n = 4) after 7 and 30 days following subretinal delivery of 1 uL saline, naked plasmid, AC-GFP, or TFA-GFP and compared to uninjected controls (UN). To assess rod photoreceptor function and signal transmission scotopic ERG was performed on dark-adapted mice and photopic ERG was performed light-adapted mice to assess cone photoreceptor function. (A) At 7 days post-injection, a significant decrease from WT amplitudes was observed in all injected eyes (p<0.05) as an immediate consequence of the injection procedure and subsequent retinal detachment, however there was no significant difference among any of the experimental groups (p>0.05) in the scotopic and photopic amplitudes. (B) By 30 days post-injection, no significant difference in scotopic and photopic amplitudes was observed between WT and injected groups (p>0.05), demonstrating the lack of toxicity associated with nanoparticle-transfection in photoreceptors. Significance was determined with ANOVA and Bonferroni's pair-wise comparison test.
Figure 7 Assessment of retinal function following subretinal injection. ERG analyses were performed in adult Balb/c mice (n = 4) after 7 and 30 days following subretinal delivery of 1 uL saline, naked plasmid, AC-GFP, or TFA-GFP and compared to uninjected controls (UN). To assess rod photoreceptor function and signal transmission scotopic ERG was performed on dark-adapted mice and photopic ERG was performed light-adapted mice to assess cone photoreceptor function. (A) At 7 days post-injection, a significant decrease from WT amplitudes was observed in all injected eyes (p<0.05) as an immediate consequence of the injection procedure and subsequent retinal detachment, however there was no significant difference among any of the experimental groups (p>0.05) in the scotopic and photopic amplitudes. (B) By 30 days post-injection, no significant difference in scotopic and photopic amplitudes was observed between WT and injected groups (p>0.05), demonstrating the lack of toxicity associated with nanoparticle-transfection in photoreceptors. Significance was determined with ANOVA and Bonferroni's pair-wise comparison test.CC BY · PubMed Central
Figure 8 Dose-response of EGFP mRNA levels to increasing amounts of nanoparticle DNA following subretinal injection. Multiple doses of the AC-GFP nanoparticles were diluted in saline and delivered via subretinal injection. qRT-PCR was then performed to assess EGFP mRNA levels in relation to photoreceptor-specific genes. An increasing trend of EGFP mRNA was detected in response to increasing levels of nanoparticle DNA delivered. At the highest dose of 4 µg of DNA, the levels of EGFP were nearly 88% of rod opsin mRNA. Lesser doses achieved expression levels near other photoreceptor-specific genes involved in blinding diseases. Rho: Rhodopsin; Sag: S-Antigen (Arrestin); Gnat1: Guanine Nucleotide Binding Protein, Alpha Transducing 1; Rds: Retinal Degeneration Slow
Figure 8 Dose-response of EGFP mRNA levels to increasing amounts of nanoparticle DNA following subretinal injection. Multiple doses of the AC-GFP nanoparticles were diluted in saline and delivered via subretinal injection. qRT-PCR was then performed to assess EGFP mRNA levels in relation to photoreceptor-specific genes. An increasing trend of EGFP mRNA was detected in response to increasing levels of nanoparticle DNA delivered. At the highest dose of 4 µg of DNA, the levels of EGFP were nearly 88% of rod opsin mRNA. Lesser doses achieved expression levels near other photoreceptor-specific genes involved in blinding diseases. Rho: Rhodopsin; Sag: S-Antigen (Arrestin); Gnat1: Guanine Nucleotide Binding Protein, Alpha Transducing 1; Rds: Retinal Degeneration SlowCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 1

  1. TH Kowalczyk, 2001, Type of polylysine counterion influences morphology and biological function of condensed DNA., Mol Ther, 3, S359

Cited by

See all 212

Metadata

Authors
Farjo, R., Skaggs, J., Quiambao, A. B., Cooper, M. J., & Naash, M. I.
Affiliations
  • University of Oklahoma Health Sciences Center (US)
  • Copernicus Therapeutics (United States) (US)
Corresponding author
Naash, Muna I.
Venue
PLoS ONE
Published
2006-12-20
Volume
1
Issue
1
Pages
e38
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2075139742
Cited by
208
References
60
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 10 · 2022: 4 · 2021: 9 · 2020: 8 · 2019: 3 · 2018: 9 · 2017: 12 · 2016: 11 · 2015: 14 · 2014: 17 · 2013: 14 · 2012: 18
FWCI
4.89
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Foundation Fighting Blindness
  • Research to Prevent Blindness
  • Oklahoma Center for the Advancement of Science and Technology
  • National Institutes of Health (EY12190)
  • National Eye Institute (P30EY012190, R56EY010609, R03EY016201, EY10609, EY016201, R01EY010609)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
non-viral gene delivery, ocular gene therapy, subretinal injection, retinal gene delivery, immune privilege, ocular tissues
MeSH terms
Animals, Base Sequence, DNA, Recombinant, Drug Carriers, Eye, Humans, Mice, Inbred BALB C, Microscopy, Fluorescence, Recombinant Proteins, Retina, RNA, Messenger, Tissue Distribution, Transfection, Genetic Therapy, Gene Expression, DNA Primers, Gene Transfer Techniques, Green Fluorescent Proteins, Mice, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles. https://app.cochat.ai/papers/10.1371/journal.pone.0000038
The paper
Farjo, R., Skaggs, J., Quiambao, A. B., Cooper, M. J., & Naash, M. I. (2006). Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles. PLoS ONE. https://doi.org/10.1371/journal.pone.0000038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.